Speaker | Affiliation | Talk title | Section |
---|---|---|---|
Guido Kroemer | Institut Gustave Roussy, France. | Interferon, viral mimicry and chemotherapy. The hallmarks of immunogenicity. | Viral vectors and interferon-based approaches in cancer immunotherapy. |
Cristian Smerdou | Center for Applied Medical Research (CIMA), Spain. | Alphavirus vectors for cancer immunotherapy. | |
Sandra Hervás-Stubbs | Center for Applied Medical Research (CIMA), Spain. | New roles for the Type I IFN system in cancer immunology. | |
David Escors | Navarrabiomed, Spain. | Ex vivo differentiation of cancer-specific myeloid-derived suppressor cells and their use in cancer immunotherapy. | |
David Sancho | Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Spain. | A dendritic cell receptor for damaged self is crucial for anti-viral immunity. | |
Bettina Weigelin | Radboud University Nijmegen, The Netherlands. | Dynamic imaging reveals serial killing of cancer cells by CTL: New strategies to overcome tumor resistance niches. | Experimental tumor imaging in immunotherapy. |
Philippe Bousso | Institut Pasteur, France. | In vivo imaging of immune tumor rejections. | |
Ignacio Melero | Center for Applied Medical Research (CIMA), Spain. | Making the most of CD137 and IL-15 for cancer immunotherapy. | Immunostimulatory monoclonal antibodies. |
Bruno Paiva | Center for Applied Medical Research (CIMA), Spain. | Monitoring myeloma in minimal residual disease: a window of opportunity for immunotherapy. | |
Paolo Ascierto | National Tumor Institute Fondazione G. Pascale, Italy. | Biomarkers for check point blockade. | |
Kohrt Holbrook | Stanford University, USA. | Stimulation of Natural Killer Cells with an Anti-CD137 Antibody Enhances the Efficacy of Trastuzumab, Cetuximab & Rituximab. | |
Noelia Casares | Center for Applied Medical Research (CIMA), Spain. | Targeting FOXP3. Development of inhibitors for immune modulation. | Novel therapeutic agents for cancer immunotherapy. |
Marisol Soengas | Spanish National Cancer Research Centre (CNIO), Spain. | New animal models for gene discovery and drug screening. | |
Fernando Pastor | Center for Applied Medical Research (CIMA), Spain. | CD137 and CD28 agonist aptamers. | |
Luis Álvarez-Vallina | Hospital Universitario Puerta de Hierro, Spain. | New antibody platforms in immunotherapy and anti-angiogenesis. |